Stereo Biotherapeutics Revenue
Biotechnology Research • • 1-10 Employees
$
Stereo Biotherapeutics revenue & valuation
| Annual revenue | $684,440 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $2,200,000 |
| Total funding | No funding |
Key Contact at Stereo Biotherapeutics
Allyson Tighe
Chief Executive Officer
Company overview
| Headquarters | XX |
| Website | |
| NAICS | 541714 |
| Employees | 1-10 |
Stereo Biotherapeutics Email Formats
Stereo Biotherapeutics uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@stereobio.com), used 75% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@stereobio.com | 75% |
{first initial}{last name} | jdoe@stereobio.com | 25% |
About Stereo Biotherapeutics
Stereo Biotherapeutics is focused on overcoming the challenge of heterogeneity in solid tumours and other diseases. Stereo was incubated and launched by Amplitude Ventures’ Pre-Amp Venture Studio.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Entry
C-Suite
Head
Employees by Department
Stereo Biotherapeutics has 4 employees across 3 departments.
Departments
Number of employees
Funding Data
Stereo Biotherapeutics has never raised funding before.
United States
Australia
South Africa
New ZealandFrequently asked questions
Stereo Biotherapeutics is located in XX.
Stereo Biotherapeutics generates an estimated annual revenue of $684,440. This revenue figure reflects the company's market position and business performance in its industry.
Stereo Biotherapeutics has an estimated valuation of $2,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.
Stereo Biotherapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
